Humacyte Stock Forecast

Sell candidate since May 29, 2026 Loss -81.31%

The Humacyte, Inc. stock price fell by -6.00% on the last day (Monday, 13th Jul 2026) from $0.0100 to $0.0094. During the last trading day the stock fluctuated 2,926.32% from a day low at $0.0076 to a day high of $0.230. The price has fallen in 5 of the last 10 days and is down by -11.32% for this period. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -22 thousand shares and in total, 2 thousand shares were bought and sold for approximately $17.24 .

The stock lies the upper part of a very wide and falling trend in the short term, and this may normally pose a very good selling opportunity for the short-term trader as reaction back towards the lower part of the trend can be expected. A break up at the top trend line at $0.0114 will firstly indicate a slower falling rate, but may be the first sign of a trend shift. Due to the high volatility and the trend direction we are not able to give forecast range for this stock. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.

HUMAW Signals & Forecast

Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. The Humacyte, Inc. stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $0.0096 and $0.0313. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Friday, June 26, 2026, and so far it has fallen -11.32%. Further fall is indicated until a new bottom pivot has been found. Volume fell along with the price during the last trading day which is technical positive. One should, however, note that this stock may have low liquidity in periods, which increases the general risk. The very low volume increases the risk and reduces the other technical signals issued.

Support, Risk & Stop-loss for Humacyte, Inc. stock

Humacyte, Inc. finds support from accumulated volume at $0.0090 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move very much during the day (volatility) and with periodic low trading volume this stock is considered to be "very high risk". During the last day, the stock moved $0.222 between high and low, or 2,926.32%. For the last week the stock has had daily average volatility of 2,422.54%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (HUMAW) For The Upcoming Trading Day Of Tuesday 14th

For the upcoming trading day on Tuesday, 14th we expect Humacyte, Inc. to open at $0.0823, and during the day (based on 14 day Average True Range), to move between $0 and $0.0774, which gives a possible trading interval of +/-$0.136 (+/-77 421.67%) up or down from last closing price. If Humacyte, Inc. takes out the full calculated possible swing range there will be an estimated 77 421.67% move between the lowest and the highest trading price during the day. ⚠️ Extreme Volatility Warning: The projected daily trading range exceeds 1000%, indicating exceptionally high volatility. This level of price movement suggests significant market uncertainty and elevated risk. Traders should exercise extreme caution, consider reduced position sizes, and implement strict risk management strategies when trading this security.

Since the stock is closer to the resistance from accumulated volume at $0.0098 (4.26%) than the support at $0.0090 (4.26%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is Humacyte, Inc. stock A Buy?

Humacyte, Inc. holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Sell to a Strong Sell candidate.

Current score: -5.981 Strong Sell Candidate Downgraded

Predicted Fair Opening Price

Predicted fair opening price on July 14, 2026 - $0.0823 ( 775.89%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk